Mostrar el registro sencillo del ítem

dc.contributor.authorStanczuk, Lukas
dc.contributor.authorMartinez-Corral, Ines
dc.contributor.authorUlvmar, Maria H
dc.contributor.authorZhang, Yang
dc.contributor.authorLaviña, Bàrbara
dc.contributor.authorFruttiger, Marcus
dc.contributor.authorAdams, Ralf H
dc.contributor.authorSaur, Dieter
dc.contributor.authorBetsholtz, Christer
dc.contributor.authorAlitalo, Kari
dc.contributor.authorGraupera, Mariona
dc.contributor.authorMäkinen, Taija
dc.date.accessioned2020-06-08T17:05:13Z
dc.date.available2020-06-08T17:05:13Z
dc.date.issued2015-03-17
dc.identifier.citationCell Rep .2015 ;10(10):1708-1721es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10291
dc.description.abstractPathological lymphatic diseases mostly affect vessels in specific tissues, yet little is known about organ-specific regulation of the lymphatic vasculature. Here, we show that the vascular endothelial growth factor receptor 3 (VEGFR-3)/p110α PI3-kinase signaling pathway is selectively required for the formation of mesenteric lymphatic vasculature. Using genetic lineage tracing, we demonstrate that part of the mesenteric lymphatic vasculature develops from cKit lineage cells of hemogenic endothelial origin through a process we define as lymphvasculogenesis. This is contrary to the current dogma that all mammalian lymphatic vessels form by sprouting from veins. Our results reveal vascular-bed-specific differences in the origin and mechanisms of vessel formation, which may critically underlie organ-specific manifestation of lymphatic dysfunction in disease. The progenitor cells identified in this study may be exploited to restore lymphatic function following cancer surgery, lymphedema, or tissue trauma.es_ES
dc.description.sponsorshipWe thank Bart Vanhaesebroeck (UCL Cancer Institute, London) for p110 alphaflox and p110 alphaD933A mice, Dimitris Kioussis (National Institute for Medical Research, London) for Vav-Cre mice, Erwin Wagner for Vegfr2flox mice, Ian Roswell and the transgenic services at the LRI for help with establishing mouse lines, Henrik Ortsater for assistance with experiments, and staff at the LRI and Uppsala University animal units for animal husbandry. We also thank the light microscopy unit at the LRI and BioVis at Uppsala University for advice and help with experiments. This study was supported by Cancer Research UK (L.S., I.M.-C., and T.M.); EMBO Young Investigator Programme, the Kjell and Marta Beijer Foundation, and the Swedish Research Council (T.M.); Fundacion Alfonso Martin Escudero (I.M.-C.); Spanish Ministry of Education (FECYT grant, postdoctoral mobility contract EDU/2934/2009; B.L.); MRC G0501711 (M.F.); Deutsche Forschunsgemeinschaft (DFG SA 137/1-3; D.S.); Ministry of Science and Innovation of Spain (grants BIO2009-09488 and SAF2010-18765 to S.O. and grant SAF2010-15661 to M.G.); European Research Council (ERC-2010-AdG-268804 to K.A. and ERC-2011-AdG-294556 to C.B.); Knut and Alice Wallenberg Foundation and the Swedish Cancer Foundation (C.B.); the Leducq Foundation (11CVD03) (K.A.); and the Marie Curie ITN (Vessel, FP7-PEOPLE-2012-ITN; K.A., R.H.A., C.B., and M.G.).es_ES
dc.language.isoenges_ES
dc.publisherCell Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectGROWTH-FACTOR-Ces_ES
dc.subjectPHENOTYPIC HETEROGENEITYes_ES
dc.subjectTRANSGENIC MICEes_ES
dc.subjectLYMPHANGIOGENESISes_ES
dc.subjectPI3Kes_ES
dc.subjectANGIOGENESISes_ES
dc.subjectORIGINes_ES
dc.subjectVASCULATUREes_ES
dc.subjectMANTEINANCEes_ES
dc.subjectPROGENITORSes_ES
dc.titlecKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID25772358es_ES
dc.format.volume10es_ES
dc.format.number10es_ES
dc.format.page1708-1721es_ES
dc.identifier.doi10.1016/j.celrep.2015.02.026es_ES
dc.contributor.funderEuropean Molecular Biology Organization 
dc.contributor.funderKjell och Märta Beijers Stiftelse 
dc.contributor.funderSwedish Research Council 
dc.contributor.funderFundación Alfonso Martín Escudero 
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.contributor.funderMedical Research Council (Reino Unido) 
dc.contributor.funderDeutsche Forschungsgemeinschaft (Alemania) 
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC) 
dc.contributor.funderKnut and Alice Wallenberg Foundation 
dc.contributor.funderFondation Leducq 
dc.contributor.funderSwedish Cancer Foundation
dc.description.peerreviewedes_ES
dc.identifier.e-issn2211-1247es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.celrep.2015.02.026es_ES
dc.identifier.journalCell reportses_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Ratones Transgénicoses_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/SAF2010-15661es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/EC/FP7/268804es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/EC/FP7/294556es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional